A new project worth further investigation: combined treatment of retinal vascular disease with intravitreal injection of antiangiogenic agents and retinal photocoagulation
10.3760/cma.j.issn.1005-1015.2013.06.001
- VernacularTitle:抗新生血管药物玻璃体腔注射与视网膜激光光凝联合治疗,视网膜血管疾病治疗值得探索的新课题
- Author:
Feng ZHANG
- Publication Type:Journal Article
- Keywords:
Retinal Diseases/therapy;
Retinal neovascularization/therapy;
Antibodies,monoclonal/therapeutic use;
Laser coagulation;
Editorial
- From:
Chinese Journal of Ocular Fundus Diseases
2013;29(6):553-555
- CountryChina
- Language:Chinese
-
Abstract:
Intravitreal injection of antiangiogenic agents is widely used to treat retinal vascular disease.This therapy can induce regression of neovascular vessels; reduce intraocular inflammation and retinal vascular permeability,and control macular edema.However the action period of these agents is short,and thus this therapy need repeated injections which cause higher operation risk and cost.Retinal laser photocoagulation therapy can close retinal capillary non-perfusion area and neovascular vessels,reduce macular edema caused by vascular leakage.However,as its therapeutic effect is based on the destruction of the retinal tissues in the lesion area,this therapy need longer time to show its effects.When the disease is controlled by this method,it may already induce some structural irreversible damages to the retina,especially the macular.This is why the visual acuity is not satisfactory in some patients,even though the disease get controlled,macular edema gets disappeared and anatomical structure of retina get improved.Properly evaluating all the pros and cons of retinal photocoagulation and intravitreal injection of antiangiogenic agents,will allow us to explore a better way to combine these two therapies to treat retinal vascular diseases.
